0001578563-25-000148.txt : 20250226 0001578563-25-000148.hdr.sgml : 20250226 20250226151613 ACCESSION NUMBER: 0001578563-25-000148 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250226 DATE AS OF CHANGE: 20250226 EFFECTIVENESS DATE: 20250226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADAPTIN BIO, INC. CENTRAL INDEX KEY: 0001938571 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 881566415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539301 FILM NUMBER: 25669510 BUSINESS ADDRESS: STREET 1: 3540 TORINGDON WAY STREET 2: SUITE 200, #250 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: (888) 609-1498 MAIL ADDRESS: STREET 1: 3540 TORINGDON WAY STREET 2: SUITE 200, #250 CITY: CHARLOTTE STATE: NC ZIP: 28277 FORMER COMPANY: FORMER CONFORMED NAME: Unite Acquisition 1 Corp. DATE OF NAME CHANGE: 20220719 D 1 primary_doc.xml X0708 D LIVE 0001938571 ADAPTIN BIO, INC. 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC NORTH CAROLINA 28277 (888) 609-1498 DELAWARE Unite Acquisition 1 Corp. Corporation true 2022 Michael Roberts c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Director President and Chief Executive Officer Patrick Gallagher c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director J. Nick Riehle c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director Anthony Zook c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director L. Arthur Hewitt c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Chief Development Officer Timothy Maness c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Chief Financial Officer Simon Pedder c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Director Executive Chairman Biotechnology Decline to Disclose 06b false 2025-02-11 false true true true true Initial sale occurred with closing of merger involving Unite Acquisition 1 Corp. (Unite), a subsidiary of Unite, and Adaptin Bio, Inc. (Private Adaptin). Private Adaptin survived as subsidiary of Unite and was renamed. Unite renamed Adaptin Bio, Inc. 0 Laidlaw & Company (UK) Ltd. 119037 None None 521 Fifth Avenue 12th Floor New York NY NEW YORK 10175 AZ ARIZONA CA CALIFORNIA CO COLORADO FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MT MONTANA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS WA WASHINGTON WI WISCONSIN true 23375010 13077849 10297161 Amounts include securities to be acquired upon the exercise of warrants. false 95 475558 true 0 Based on total amount sold as of date of first sale. In addition to the sales commissions, warrants to purchase an aggregate of 270,204 shares of our common stock were also issued to the placement agent. 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false ADAPTIN BIO, INC. /s/ Michael J. Roberts Michael J. Roberts President and Chief Executive Officer 2025-02-24